Private Harbour Investment Management & Counsel’s Heron Therapeutics HRTX Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,997	Closed	-$74K	–	54
2022 Q1	$74K	Sell	12,997 -1,459	-10%	-$10.7K	0.06%	58
2021 Q4	$132K	Sell	14,456 -1,299	-8%	-$13.3K	0.11%	59
2021 Q3	$168K	Sell	15,755 -275	-2%	-$3.35K	0.15%	56
2021 Q2	$249K	Sell	16,030 -1,975	-11%	-$31.4K	0.22%	56
2021 Q1	$292K	Sell	18,005 -165	-0.9%	-$2.94K	0.26%	52
2020 Q4	$385K	Sell	18,170 -50	-0.3%	-$869	0.38%	50
2020 Q3	$270K	Sell	18,220 -75	-0.4%	-$1.17K	0.29%	51
2020 Q2	$269K	Sell	18,295 -75	-0.4%	-$1.23K	0.29%	51
2020 Q1	$216K	Sell	18,370 -425	-2%	-$7.99K	0.25%	57
2019 Q4	$442K	Sell	18,795 -1,090	-5%	-$24.1K	0.45%	52
2019 Q3	$368K	Hold	19,885	–	–	0.38%	56
2019 Q2	$370K	Sell	19,885 -20	-0.1%	-$400	0.38%	58
2019 Q1	$486K	Buy	+19,905	New	+$521K	0.5%	57

Other funds holding HRTX

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Private Harbour Investment Management & Counsel's HRTX Position: Q2 2022 in Review

Private Harbour Investment Management & Counsel sold out of Heron Therapeutics (HRTX) in Q2 2022, closing a stake of 12,997 shares — an estimated $74K sold.

Private Harbour Investment Management & Counsel first reported a position in HRTX in Q1 2019 and held it in 13 quarters. The position peaked at $486K in Q1 2019. 174 funds tracked by Wall St. Rank hold HRTX as of Q2 2022.

Private Harbour Investment Management & Counsel reported no remaining Heron Therapeutics position as of Q2 2022 after selling out during the quarter.
Private Harbour Investment Management & Counsel sold 12,997 Heron Therapeutics shares in Q2 2022, an estimated $74K.
Private Harbour Investment Management & Counsel first reported a position in Heron Therapeutics in Q1 2019 and held it in 13 quarters.
Private Harbour Investment Management & Counsel's Heron Therapeutics position peaked at $486K in Q1 2019.
174 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2022.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q2 2022, filed 13 Jul 2022.